PRISM BioLab Co.,LTD (TYO:206A)

PRISM BioLab Co.,LTD Balance Sheet

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
Cash & Equivalents	2,916	4,392	1,134	1,687
Cash & Short-Term Investments	2,916	4,392	1,134	1,687
Cash Growth	-33.62%	287.32%	-32.78%	-
Accounts Receivable	-	-	-	21
Other Receivables	52.83	54.89	40.25	-
Receivables	52.83	54.89	40.25	21
Prepaid Expenses	54.41	29.22	17.93	14
Other Current Assets	16.08	6.96	5.48	10
Total Current Assets	3,039	4,483	1,198	1,732
Property, Plant & Equipment	0	-	0	-
Long-Term Investments	-	-	-	8
Other Long-Term Assets	46.8	45.47	13.82	-
Total Assets	3,086	4,529	1,211	1,740
Accounts Payable	78.72	57.68	38.6	-
Accrued Expenses	21.17	8.28	5.06	2
Current Income Taxes Payable	25.96	48.07	1.21	54
Current Unearned Revenue	236.59	900.07	13.16	-
Other Current Liabilities	7.64	5.78	5.21	9
Total Current Liabilities	370.08	1,020	63.24	65
Other Long-Term Liabilities	6.78	5.8	0.17	1
Total Liabilities	376.86	1,026	63.41	66
Common Stock	1,731	1,714	12.25	12
Additional Paid-In Capital	3,347	3,331	1,629	1,628
Retained Earnings	-2,376	-1,543	-493.22	33
Comprehensive Income & Other	7.12	0.42	0.42	1
Shareholders' Equity	2,709	3,503	1,148	1,674
Total Liabilities & Equity	3,086	4,529	1,211	1,740
Net Cash (Debt)	2,916	4,392	1,134	1,687
Net Cash Growth	-33.62%	287.32%	-32.78%	-
Net Cash Per Share	79.81	140.30	41.08	61.68
Filing Date Shares Outstanding	36.92	31.3	31.35	27.35
Total Common Shares Outstanding	36.81	31.3	31.35	27.35
Working Capital	2,669	3,463	1,134	1,667
Book Value Per Share	73.59	111.90	36.61	61.21
Tangible Book Value	2,709	3,503	1,148	1,674
Tangible Book Value Per Share	73.59	111.90	36.61	61.21
Buildings	23.43	20.42	0.13	-
Machinery	330.53	254.12	64.69	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.